Sun Pharmaceutical’s $576 Million Acquisition of Concert Pharmaceuticals

Davis Polk advised Sun Pharmaceutical, and Goodwin Procter advised Concert Pharmaceuticals.Sun Pharmaceutical Industries Limited announced its acquisition of Concert Pharmaceuticals Inc., through a tender offer for an upfront…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Pietro Martinoia

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here